Long, G.V. Flaherty, K.T. Stroyakovskiy, D. Gogas, H. Levchenko, E. de Braud, F. Larkin, J. Garbe, C. Jouary, T. Hauschild, A. Chiarion-Sileni, V. Lebbe, C. Mandalà, M. Millward, M. Arance, A. Bondarenko, I. Haanen, J.B.A.G. Hansson, J. Utikal, J. Ferraresi, V. Mohr, P. Probachai, V. Schadendorf, D. Nathan, P. Robert, C. Ribas, A. Davies, M.A. Lane, S.R. Legos, J.J. Mookerjee, B. Grob, J.-J., Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/ K-mutant melanoma: Long-term survival and safety analysis of a phase 3 study, Annals of Oncology, (28), 1631-1639, 2017, Oxford University Press, 0923-7534, 1569-8041